ASRT opposes NRC proposed changes to radiopharmaceutical training and experience standards

Huge Two-Day Clean Sweep Auction July 24-25th. Click Here to Bid!

Current Location:
> This Story

Forward Printable StoryPrint Comment




Molecular Imaging Homepage

MEDraysintell releases its new Early Stage Radiopharmaceuticals Report

The Innovation Center for Translational Imaging of Tel Aviv University acquires MILabs VECTor PET/SPECT/CT system

New system overcomes challenges of nanotheranostics

Bruker acquires preclinical and molecular imaging research software provider PMOD Technologies

Nuclear stress test helps identify heart attack risk in people with diabetes

New combination therapy established as safe and effective for prostate cancer

Standard defines measurement methods for performance parameters of SPECT scanners

Blue Earth Diagnostics announces results from investigational clinical study of safety and effectiveness of 18F-Fluciclovine PET

Scientists discover new method for developing tracers used for medical imaging

Radiology's role in determining the impact of Amyloid PET imaging on real-world Alzheimer's disease and dementia care

ASRT opposes NRC proposed changes to radiopharmaceutical training and experience standards

Press releases may be edited for formatting or style
The American Society of Radiologic Technologists opposes the Nuclear Regulatory Commission’s proposal to reduce training and experience requirements for physicians administering radiopharmaceuticals.

Radionuclide therapy can be dangerous if administered incorrectly. As with other radiologic procedures that use medical radiation, it is vital that physicians and nuclear medicine technologists with extensive levels of training and experience perform radionuclide therapy.

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED

The NRC is recommending reducing the number of personnel training and experience hours for an authorized user from 700 to 400. Limiting training and experience hours could compromise patient safety. Authorized users who can administer radiopharmaceuticals under an NRC license have followed the 700-hour requirement for years and it has resulted in exemplary patient care.

ASRT strongly believes that everyone involved in the administration of radiopharmaceuticals must be educationally prepared and clinically competent to do so. The current NRC requirements ensure that the physicians and the nuclear medicine technologists who assist them are prepared to provide safe and high-quality patient care. As such, ASRT disagrees with the proposed changes to the physician authorized user requirements.

The Society submitted a letter to the NRC on July 1, 2019, expressing its opposition to the proposed requirement changes.

ASRT represents nearly 4,700 nuclear medicine technologists. The society’s position on this measure aligns with Society of Nuclear Medicine and Molecular Technologists, which represents 17,000 members, including physicians, technologists, scientists, physicists, chemists and pharmacists, all participating in the field of nuclear medicine and molecular imaging.

Molecular Imaging Homepage

You Must Be Logged In To Post A Comment